Sfoglia per AUTORE
KOSTAKOGLU L
Collezione AO Cuneo

  

Items : 6

A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA. in EJHaem / EJHaem. 2022 Mar 24;3(2):406-414. doi: 10.1002/jha2.421. eCollection 2022 May.
2022
AO Cuneo

Kostakoglu L; Dalmasso F; Berchialla P; Pierce LA; Vitolo U; Martelli M; Sehn LH; Trn?ný M; Nielsen TG; Bolen CR; Sahin D; Lee C; El-Galaly TC; Mattiello F; Kinahan PE; Chauvie S;

PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma. in PET clinics / PET Clin. 2019 Jul;14(3):317-329. doi: 10.1016/j.cpet.2019.03.002.
2019
AO Cuneo

Chauvie S; Kostakoglu L;

Metabolic Tumor Volume Metrics in Lymphoma. in Seminars in nuclear medicine / Semin Nucl Med. 2018 Jan;48(1):50-66. doi: 10.1053/j.semnuclmed.2017.09.005.
2018
AO Cuneo

Kostakoglu L; Chauvie S;

2014
AO Cuneo

Gallamini A; Barrington SF; Biggi A; Chauvie S; Kostakoglu L; Gregianin M; Meignan M; Mikhaeel GN; Loft A; Zaucha JM; Seymour JF; Hofman MS; Rigacci L; Pulsoni A; Coleman M; Dann EJ; Trentin L; Casasnovas O; Rusconi C; Brice P; Bolis S; Viviani S; Salvi F; Luminari S; Hutchings M;

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2013 May;54(5):683-90. doi: 10.2967/jnumed.112.110890. Epub 2013 Mar 20.
2013
AO Cuneo

Biggi A; Gallamini A; Chauvie S; Hutchings M; Kostakoglu L; Gregianin M; Meignan M; Malkowski B; Hofman MS; Barrington SF;

Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials? in Blood / Blood. 2012 Dec 13;120(25):4913-20. doi: 10.1182/blood-2012-03-403790. Epub 2012 Aug 28.
2012
AO Cuneo

Gallamini A; Kostakoglu L;